Ping An-Shionogi Co., Ltd.
https://www.pingan-shionogi.cn/en/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Ping An-Shionogi Co., Ltd.
Shionogi Reveals Strategy For COVID-19 Drug Xocova
Shionogi is hoping to demonstrate the efficacy of its oral COVID-19 candidate Xocova through an appropriate primary endpoint in its Phase III trial, while the Japanese firm is also eyeing global expansion for the drug should a world-first domestic approval be granted.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Services
-
Digital Health
- Disease Management
- Other Names / Subsidiaries
-
- Ping An-Shionogi JV
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ping An-Shionogi Co., Ltd.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice